SCHEMBL9917839

SCHEMBL9917839

CC(C)C(=O)OCCO[C@H](CO)n1cnc2c(N)nc(N)nc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 5/20 0.51
▸ CDK2 P24941 5/20 0.51
▸ CCNB1 P14635 3/20 0.51
▸ CCNE1 P24864 3/20 0.51
▸ AHCY P23526 4/20 0.40
▸ HDAC1 Q13547 2/20 0.36
▸ HDAC2 Q92769 2/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ PRKACA P17612 1/20 0.36
▸ CCNA2 P20248 1/20 0.36
▸ PRKACG P22612 1/20 0.36
▸ PRKACB P22694 1/20 0.36
▸ MAPK3 P27361 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ HINT1 P49773 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ HSP90B1 P14625 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9917837 0.84 CDK1 (0.54) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL29324082 0.80 P2RX7 (0.39) CDK1CDK2AHCYHDAC1HDAC2
SCHEMBL9584502 0.77 CDK1 (0.49) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL13189440 0.76 CDK1 (0.54) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL9584514 0.73 PDE3A (0.59) CDK1CDK2CCNB1CCNE1MAPK1
SCHEMBL29325429 0.72 CDK1 (0.46) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL9827534 0.71 CDK1 (0.37) CDK1CDK2CCNB1CCNE1HDAC1
SCHEMBL21101443 0.70 CDK1 (0.52) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL28083712 0.70 CDK1 (0.76) CDK1CDK2CCNB1CCNE1AHCY
SCHEMBL756644 0.70 CDK1 (1.00) CDK1CDK2CCNB1CCNE1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012078416-A2 MONOPHOSPHATE PRODRUGS OF DAPD AND ANALOGS THEREOF RFS PHARMA, LLC (US) 2012-06-14 — — WO disclosed
WO-2009018106-A2 STEREOSELECTIVE PROCESS FOR PREPARING PURINE DIOXOLANE NUCLEOSIDE DERIVATIVES RFS PHARMA, LLC (US) 2009-02-05 — — WO disclosed
Send feedback